Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of DFN-15 in Episodic Migraine
NCT02472418Phase 2Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jun 2015
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of celecoxib oral solution in migraine (3 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Pain Free at 2 hours. Started Jun 2015; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02472418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02472418.